Mesalamine Controlled-Release Capsules and Moxifloxacin Intravenous
Determining the interaction of Mesalamine Controlled-Release Capsules and Moxifloxacin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: moxifloxacin
Brand name: Avelox, Avelox IV
Synonyms: Moxifloxacin, Moxifloxacin (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Moxifloxacin Tablets
- Mesalamine Controlled-Release Capsules-Moxilin
- Mesalamine Controlled-Release Capsules-MPI DTPA
- Mesalamine Controlled-Release Capsules-MS Contin
- Mesalamine Controlled-Release Capsules-MST
- Mesalamine Controlled-Release Capsules-MTX Support
- Moxifloxacin Intravenous-Mesalamine Delayed Release Tablets
- Moxifloxacin Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Moxifloxacin Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Moxifloxacin Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Moxifloxacin Intravenous-Mesalamine rectal
- Moxifloxacin Intravenous-Mesalamine Rectal Enema